2023
DOI: 10.1007/s10549-023-06865-8
|View full text |Cite
|
Sign up to set email alerts
|

Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…Studies have been conducted that investigate the ability of different imaging methods in the diagnosis of residual disease. For example, the study of Molly P. Hogan et al has shown that CEM is an acceptable alternative to breast MRI for the diagnosis of residual disease after neoadjuvant treatment [61].…”
Section: Contrast-enhanced Mammography (Cem)mentioning
confidence: 99%
“…Studies have been conducted that investigate the ability of different imaging methods in the diagnosis of residual disease. For example, the study of Molly P. Hogan et al has shown that CEM is an acceptable alternative to breast MRI for the diagnosis of residual disease after neoadjuvant treatment [61].…”
Section: Contrast-enhanced Mammography (Cem)mentioning
confidence: 99%
“…These cells are undetectable and can unpredictably lead to recurrence and metastasis. Such drug resistance prevents anti-cancer treatments, so it is necessary to improve diagnostic methods [57] Studies have been conducted in the field of investigating the ability of different imaging methods in the diagnosis of residual disease, for example, the study of Molly P. Hogan et al has shown that CEM is an acceptable alternative to breast MRI for the diagnosis of residual disease after neoadjuvant treatment [58].…”
Section: Contrast-enhanced Mammography (Cem)mentioning
confidence: 99%